Novartis AG (NVS) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Novartis AG (NVS) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 26, 2024 (20:34)

Sector: Healthcare

The share price of Novartis AG (NVS) now

Latest session on the 25th of July for
Novartis AG is positive
Trading Volume: 1248492
Open: 109.38 /  High: 110.51 /  Low: 109.36
What analysts predict: $114.26
52-week High/Low: $112.48 / $88.33

50/200 Day Moving Average: $105.62 / $100.57

This figure corresponds to the Average Price over the previous 50/200 days. For Novartis AG stocks, the 50-day moving average is the support level today.

For Novartis AG stocks, the 200-day moving average is the support level today.

Are you interested in Novartis AG stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Novartis AG stock price in 2024, 2025, 2026, 2027, 2028. How much will one Novartis AG share be worth in 2024 - 2028?

When should I take profit in Novartis AG stock? When should I record a loss on Novartis AG stock? What are analysts' forecasts for Novartis AG stock? What is the future of Novartis AG stock? We forecast Novartis AG stock performance using neural networks based on historical data on Novartis AG stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Novartis AG stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Novartis AG shares. This happens once a day.


Historical and forecast chart of Novartis AG stock

The chart below shows the historical price of Novartis AG stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Novartis AG stock price can be found in the table below.

Long-term forecasts by years.

Novartis AG produces rec. and over the counter. medications for the treatment of cardiovascular, respiration. and infec. diseases, diseases of the gastrointestinal tract and urinary system, as well as for oncology, neurology, transplantation, dermatology. Produces vaccines and diagnostics, eye and lek. preparations for animals.

Novartis AG daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 28 110.40 110.08 110.76 0.61
Jul 29 110.90 110.38 111.19 0.73
Jul 30 111.02 110.49 111.90 1.28
Jul 31 111.51 110.73 112.20 1.33
Aug 01 111.12 110.29 111.86 1.43
Aug 02 111.16 110.76 111.44 0.61
Aug 03 110.82 110.35 111.04 0.62
Aug 04 110.54 109.78 111.36 1.44
Aug 05 111.53 110.86 112.21 1.22
Aug 06 111.72 111.01 112.34 1.20
Aug 07 111.98 111.31 112.50 1.07
Aug 08 111.67 111.20 111.91 0.63
Aug 09 112.75 112.20 113.26 0.94
Aug 10 113.06 112.23 113.61 1.23
Aug 11 112.64 112.12 113.05 0.82
Aug 12 113.28 112.76 114.14 1.23
Aug 13 113.08 112.24 113.45 1.08
Aug 14 113.45 112.84 113.72 0.78
Aug 15 112.42 112.01 112.79 0.69
Aug 16 111.42 110.77 111.84 0.97
Aug 17 111.38 110.57 111.69 1.01
Aug 18 110.36 109.50 111.11 1.47
Aug 19 110.21 109.94 110.99 0.95
Aug 20 110.72 109.87 111.55 1.53
Aug 21 111.74 111.25 112.49 1.11
Aug 22 112.14 111.64 112.97 1.20
Aug 23 111.44 110.65 111.68 0.94
Aug 24 110.56 110.19 111.11 0.83
Aug 25 109.92 109.07 110.70 1.49
Aug 26 109.75 109.30 110.50 1.09

Novartis AG Daily Price Targets


Novartis AG Stock Forecast 07-28-2024.

Forecast target price for 07-28-2024: $110.40.
Positive dynamics for Novartis AG shares will prevail with possible volatility of 0.609%.
Pessimistic target level: 110.08
Optimistic target level: 110.76

Novartis AG Stock Forecast 07-29-2024.

Forecast target price for 07-29-2024: $110.90.
Positive dynamics for Novartis AG shares will prevail with possible volatility of 0.728%.
Pessimistic target level: 110.38
Optimistic target level: 111.19

Novartis AG Stock Forecast 07-30-2024.

Forecast target price for 07-30-2024: $111.02.
Positive dynamics for Novartis AG shares will prevail with possible volatility of 1.260%.
Pessimistic target level: 110.49
Optimistic target level: 111.90

Novartis AG Stock Forecast 07-31-2024.

Forecast target price for 07-31-2024: $111.51.
Positive dynamics for Novartis AG shares will prevail with possible volatility of 1.312%.
Pessimistic target level: 110.73
Optimistic target level: 112.20

Novartis AG Stock Forecast 08-01-2024.

Forecast target price for 08-01-2024: $111.12.
Negative dynamics for Novartis AG shares will prevail with possible volatility of 1.411%.
Pessimistic target level: 110.29
Optimistic target level: 111.86

Novartis AG Stock Forecast 08-02-2024.

Forecast target price for 08-02-2024: $111.16.
Positive dynamics for Novartis AG shares will prevail with possible volatility of 0.608%.
Pessimistic target level: 110.76
Optimistic target level: 111.44

NVS (NVS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 111.16 108.49 112.63 3.67
Sep. 114.19 113.27 115.14 1.63
Oct. 113.18 111.55 115.08 3.07
Nov. 111.37 108.56 114.31 5.03
Dec. 112.22 108.94 114.33 4.71

Novartis AG forecast for this year


Novartis AG Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $111.161. Pessimistic: $108.49. Optimistic: $112.63


Novartis AG Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $114.185. Pessimistic: $113.27. Optimistic: $115.14


Novartis AG Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $113.18. Pessimistic: $111.55. Optimistic: $115.08


Novartis AG Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $111.369. Pessimistic: $108.56. Optimistic: $114.31


Novartis AG Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $112.215. Pessimistic: $108.94. Optimistic: $114.33



Novartis AG (NVS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 111.86 109.49 114.81 4.64
Feb 114.14 110.49 115.69 4.50
Mar 116.42 113.02 117.59 3.88
Apr 114.65 111.72 115.75 3.49
May 113.41 110.24 115.09 4.22
Jun 110.19 108.34 112.44 3.65
Jul 109.13 108.04 110.18 1.94
Aug 107.39 104.90 110.18 4.79
Sep 108.98 106.01 110.85 4.37
Oct 111.72 108.64 112.75 3.65
Nov 111.01 108.70 112.92 3.74
Dec 110.43 109.33 112.77 3.06

Novartis AG (NVS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 114.14 110.63 116.20 4.79
Feb 114.37 111.58 115.38 3.29
Mar 110.07 107.78 111.74 3.55
Apr 108.57 107.57 109.53 1.78
May 107.75 105.55 109.95 4.00
Jun 109.47 106.54 112.27 5.11
Jul 110.30 108.05 111.67 3.24
Aug 113.30 110.04 116.61 5.64
Sep 112.90 109.87 115.15 4.59
Oct 111.18 108.29 113.05 4.21
Nov 110.69 108.74 114.10 4.70
Dec 108.88 106.05 110.23 3.79

Novartis AG (NVS) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 110.75 107.91 111.81 3.49
Feb 112.61 111.44 115.09 3.17
Mar 111.17 110.19 114.10 3.43
Apr 112.19 109.23 113.67 3.91
May 114.48 111.73 116.59 4.16
Jun 115.30 112.03 118.30 5.30
Jul 114.20 111.23 116.53 4.55
Aug 114.47 113.28 116.17 2.48
Sep 117.95 115.78 118.89 2.62
Oct 122.62 118.70 124.83 4.91
Nov 120.56 119.36 122.68 2.71
Dec 118.58 116.26 120.77 3.73

Novartis AG (NVS) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 117.49 115.57 118.43 2.42
Feb 115.57 112.93 117.46 3.86
Mar 116.17 115.24 118.77 2.97
Apr 117.93 114.82 119.21 3.68
May 122.46 120.60 125.45 3.87
Jun 124.52 122.03 126.51 3.54
Jul 129.20 127.13 131.32 3.19
Aug 134.01 131.92 136.85 3.60
Sep 136.04 134.03 138.60 3.30
Oct 135.12 132.85 139.39 4.69
Nov 134.47 130.44 136.73 4.60
Dec 132.32 129.99 135.49 4.06

Novartis AG information and performance

Novartis AG Address

LICHTSTRASSE 35, BASEL, CH

Market Capitalization: 222 481 089 000 $

Market capitalization of the Novartis AG is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of NVS shares in the company outstanding by the market price of one share.

EBITDA: 19 648 000 000 $

EBITDA of Novartis AG is earnings before interest, income tax and depreciation of assets.

PE Ratio: 22.47

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 5.09

Price/earnings to growth

DPS: 3.919

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0346

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 4.89

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.43
Quarterly Revenue Growth YOY: 0.096
Trailing PE: 22.47

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 13.24

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.41

Enterprise Value (EV) /Revenue

EV To EBITDA: 11.27

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 2024580000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Novartis AG (NVS) stock dividend

Novartis AG last paid dividends on 03/07/2024. The next scheduled payment will be on 04/19/2024. The amount of dividends is $3.919 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.